CJC-1295 No DAC

Modified GRF 1-29

AI explanation

CJC-1295 No DAC Explained

CJC-1295 No DAC is a synthetic peptide that tells your pituitary gland to produce more growth hormone. People use it because growth hormone naturally declines with age, and this peptide essentially reminds your body to make more of it—similar to how your body did when you were younger.

Here's how it actually works: Your pituitary gland is like a hormone factory, and growth hormone is one of its key products. Normally, a natural signal called GHRH arrives and says "time to release growth hormone." CJC-1295 No DAC mimics that signal perfectly. It's a slight tweak on the natural messenger—just stable enough to stick around for 30 to 60 minutes instead of the original 2 minutes—but not so stable that it floods your system constantly.

The "No DAC" part matters because without it, the peptide creates pulses rather than a constant drip. Your body naturally releases growth hormone in waves, and this version respects that rhythm, which feels more natural to your system.

When combined with other peptides like GHRP-2, they work as a team: one increases how much hormone gets released per pulse, the other increases how often those pulses happen. Together, they produce significantly more growth hormone than either could alone.

Dosage Information

Typical Dose

100 mcg per dose

Frequency

2-3 times daily, typically combined with a GHRP

Morning or evening

Administration

Subcutaneous injection

Half-Life

25–30 minutes

Notes

Almost always stacked with a GHRP (Ipamorelin, GHRP-2, or GHRP-6) for synergistic GH release. Administer on empty stomach and avoid eating for 30-40 minutes post-injection to maximize GH pulse.

Why this matters

Very short half-life without DAC; typically dosed before bed or pre-workout for a GH pulse.

Protocol cycle

as needed· Continuous dosing protocol, no cycling mentioned

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

4

unit mark

020406080100

Draw 4 units for your 100mcg dose of CJC-1295 No DAC

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does CJC-1295 No DAC sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.58

Clinical trials
1.0035%
Literature
0.4030%
Community
0.0020%
Completeness
0.7515%
1 RCTs1 clinical trials

Potential Side Effects

Water retention (uncommon)Tingling or numbness in extremities (uncommon)Fatigue (uncommon)Injection site irritation (uncommon)
Pep Talk

CJC-1295 No DAC discussions

Quick Facts

Administration
Subcutaneous injection
Typical Dose
100 mcg per dose
Frequency
2-3 times daily, typically combined with a GHRP
References
0 curated + 14 from PubMed
Clinical Trials
13 registered
Evidence Score
0.6 / 100

Frequently Asked Questions about CJC-1295 No DAC

What is CJC-1295 No DAC?

CJC-1295 No DAC (also called Modified GRF 1-29 or Mod GRF 1-29) is a modified version of the first 29 amino acids of GHRH without the Drug Affinity Complex (DAC) used in standard CJC-1295. Without DAC the peptide has a shorter half-life of 30-60 minutes compared to CJC-1295 DAC's week-long duration. This shorter half-life is often considered advantageous as it produces a more physiological pulsatile GH release pattern rather than the continuous elevation from CJC-1295 with DAC. It is one of the most widely used GHRH analogs in combination with GHRP peptides.

How does CJC-1295 No DAC work?

Mod GRF 1-29 binds to GHRH receptors on pituitary somatotrophs stimulating GH synthesis and pulsatile release through the same mechanism as endogenous GHRH. The four amino acid substitutions from native GHRH 1-29 improve stability against enzymatic degradation extending the half-life from the 2 minutes of native GHRH to 30-60 minutes without altering receptor binding affinity. When combined with a GHRP peptide (such as Ipamorelin or GHRP-2) the two compounds work synergistically — GHRH analogs increase the amount of GH released per pulse while GHRPs increase the frequency and amplitude of pulses producing GH release significantly greater than either compound alone.

What is the recommended dosage for CJC-1295 No DAC?

The typical dose is 100 mcg per dose. 2-3 times daily, typically combined with a GHRP. Administration: Subcutaneous injection. Almost always stacked with a GHRP (Ipamorelin, GHRP-2, or GHRP-6) for synergistic GH release. Administer on empty stomach and avoid eating for 30-40 minutes post-injection to maximize GH pulse.

What are the side effects of CJC-1295 No DAC?

Water retention (uncommon). Tingling or numbness in extremities (uncommon). Fatigue (uncommon). Injection site irritation (uncommon)

What is the CJC-1295 No DAC cycle protocol?

CJC-1295 No DAC is typically cycled as needed. Continuous dosing protocol, no cycling mentioned

Questions reflect common community inquiries. This is not medical advice.